These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8946307)

  • 1. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality.
    Larsson LG; Nyström L; Wall S; Rutqvist L; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L
    J Med Screen; 1996; 3(3):129-32. PubMed ID: 8946307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the Swedish randomised mammography trials: total mortality pattern and the representivity of the study cohorts.
    Nystrom L; Larsson LG; Wall S; Rutqvist LE; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabar L
    J Med Screen; 1996; 3(2):85-7. PubMed ID: 8849766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.
    Nyström L; Andersson I; Bjurstam N; Frisell J; Nordenskjöld B; Rutqvist LE
    Lancet; 2002 Mar; 359(9310):909-19. PubMed ID: 11918907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer screening with mammography: overview of Swedish randomised trials.
    Nyström L; Rutqvist LE; Wall S; Lindgren A; Lindqvist M; Rydén S; Andersson I; Bjurstam N; Fagerberg G; Frisell J
    Lancet; 1993 Apr; 341(8851):973-8. PubMed ID: 8096941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
    Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
    J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess mortality from breast cancer in relation to mammography screening in northern Sweden.
    Lenner P; Jonsson H
    J Med Screen; 1997; 4(1):6-9. PubMed ID: 9200054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.
    Tabár L; Fagerberg CJ; Gad A; Baldetorp L; Holmberg LH; Gröntoft O; Ljungquist U; Lundström B; Månson JC; Eklund G
    Lancet; 1985 Apr; 1(8433):829-32. PubMed ID: 2858707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare.
    Int J Cancer; 1996 Dec; 68(6):693-9. PubMed ID: 8980168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point.
    Tabar L; Duffy SW; Yen MF; Warwick J; Vitak B; Chen HH; Smith RA
    J Med Screen; 2002; 9(4):159-62. PubMed ID: 12518005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
    J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
    Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis.
    Magnus MC; Ping M; Shen MM; Bourgeois J; Magnus JH
    J Womens Health (Larchmt); 2011 Jun; 20(6):845-52. PubMed ID: 21413892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Swedish breast cancer detection results for women aged 40-49.
    Tabar L; Duffy SW; Burhenne LW
    Cancer; 1993 Aug; 72(4 Suppl):1437-48. PubMed ID: 8339236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization.
    Larsson LG; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L; Nyström L
    J Natl Cancer Inst Monogr; 1997; (22):57-61. PubMed ID: 9709277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.